TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32273003

Group type: EXPERIMENTAL
Intervention: Penicillin and Gentamicin (PG)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Cefquinome (CEF)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Untreated horses (NOAMD)
Number of subjects: 86
Study: 34953401

Group type: COMPARATOR
Intervention: Intravenous 0.9% NaCl 500 ml + KCL 20 mEq over 4 h pre-cisplatin 40 mg/m2 weekly for 7-8 weeks (Control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intravenous 0.9% NaCl 500 ml + KCL 20 mEq + additional 16 mEq magnesium (Mg group)
Number of subjects: 30
Study: 34210061

Group type: EXPERIMENTAL
Intervention: Ontario Brain Injury Association Peer Support Program (weekly intervention)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 13
Study: 32132826

Group type: EXPERIMENTAL
Intervention: Eye-closed and weighted multi-ball training (EWMT) for 10 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal training without eye-closed and weighted swing intervention (Control Group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Eye-closed and weighted multi-ball training (EWMT)
Number of subjects: 48
Study: 35562656

Group type: EXPERIMENTAL
Intervention: SMS-only intervention
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: SMS + pedometer intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 150
Study: 35689400

Group type: EXPERIMENTAL
Intervention: Hypobaric hypoxia
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 22
Study: 34633483

Group type: EXPERIMENTAL
Intervention: Workplace bullying exposure
Number of subjects: 1193

Group type: COMPARATOR
Intervention: Social support
Number of subjects: 1193
Study: 35579313

Group type: EXPERIMENTAL
Intervention: Silver antimicrobial dressing in addition to standard of care (SoC) for 2 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard of care (SoC) only
Number of subjects: 100
Study: 33515785

Group type: EXPERIMENTAL
Intervention: Safety Planning Intervention
Number of subjects: 484

Group type: COMPARATOR
Intervention: Control (risk factors and warning signs)
Number of subjects: 484
Study: 34004417

Group type: EXPERIMENTAL
Intervention: New cancer cachexia staging system
Number of subjects: 1325
Study: 32531259

Group type: EXPERIMENTAL
Intervention: Sofosbuvir (200 mg) plus ribavirin (200 mg) for 24 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sofosbuvir (400 mg) plus ribavirin (200 mg) for 24 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Ledipasvir (90 mg) plus sofosbuvir (400 mg) for 12 weeks
Number of subjects: 38
Study: 36351247

Group type: EXPERIMENTAL
Intervention: Pitch-based musical training (carillon group)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Rhythm-based musical training (drum group)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Handcraft learning (control group)
Number of subjects: 61
Study: 33781269

Group type: EXPERIMENTAL
Intervention: CAF-3 (3 mg/kg/b.m.)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: CAF-6 (6 mg/kg/b.m.)
Number of subjects: 21

Group type: COMPARATOR
Intervention: PLAC (Placebo)
Number of subjects: 21
Study: 32199492

Group type: EXPERIMENTAL
Intervention: ChAd3‐EBO‐Z/MenACWY‐TT
Number of subjects: 600

Group type: COMPARATOR
Intervention: MenACWY‐TT/ChAd3‐EBO‐Z
Number of subjects: 600
Study: 34984983

Group type: EXPERIMENTAL
Intervention: BioFreedom stent
Number of subjects: 3151

Group type: COMPARATOR
Intervention: Orsiro stent
Number of subjects: 3151
Study: 34449029

Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block (ESPB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 36014925

Group type: EXPERIMENTAL
Intervention: Melatonin administration for 12 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 27
Study: 33103603

Group type: EXPERIMENTAL
Intervention: Glucagon bolus (50 µg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Glucagon infusion (50 µg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Esmolol (1.25 mg/kg bolus + 0.75 mg/kg/min infusion)
Number of subjects: 10
Study: 36501128

Group type: EXPERIMENTAL
Intervention: Indulgent breakfast (500 kcal label)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sensible breakfast (250 kcal label)
Number of subjects: 50
Study: 32484891

Group type: EXPERIMENTAL
Intervention: Processing speed training
Number of subjects: 2097

Group type: EXPERIMENTAL
Intervention: Memory training
Number of subjects: 2097

Group type: EXPERIMENTAL
Intervention: Reasoning training
Number of subjects: 2097

Group type: COMPARATOR
Intervention: No contact control
Number of subjects: 2097
Study: 32209625

Group type: EXPERIMENTAL
Intervention: G-CSF (filgrastim)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (indistinguishable glucose solution 5%)
Number of subjects: 76
Study: 36375780

Group type: EXPERIMENTAL
Intervention: 1 g of ferric carboxymaltose (FCM)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo (100 mL of physiological serum)
Number of subjects: 195
Study: 34452671

Group type: EXPERIMENTAL
Intervention: iCALM Telehealth Program
Number of subjects: 40

Group type: COMPARATOR
Intervention: waitlist
Number of subjects: 40
Study: 32339402

Group type: EXPERIMENTAL
Intervention: 24-hr ocular dimensional profile recorded with a contact lens sensor (CLS)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Single tonometric intraocular pressure (IOP) reading
Number of subjects: 65
Study: 33387096

Group type: EXPERIMENTAL
Intervention: Brief HRV biofeedback intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preference for biofeedback devices
Number of subjects: 40
Study: 36249728

Group type: EXPERIMENTAL
Intervention: U-shaped flap without rolling with temporary crown placement (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: U-shaped flap with rolling with temporary crown placement (Group B)
Number of subjects: 40
Study: 33756064

Group type: EXPERIMENTAL
Intervention: Fluorinol-containing toothpaste
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium calcium phosphosilicate-containing toothpaste
Number of subjects: 0
Study: 32965395

Group type: EXPERIMENTAL
Intervention: Tocilizumab plus standard of care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 0
Study: 33975807

Group type: EXPERIMENTAL
Intervention: Handout Assisted Consent (HC)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Verbal Consent (VC)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups (HC and VC)
Number of subjects: 79
Study: 34299960

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (educational on healthy habits, nutritional intervention, telematic aerobic and strength exercise)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 23
Study: 32228177

Group type: EXPERIMENTAL
Intervention: Circulating levels of uric acid
Number of subjects: 979

Group type: COMPARATOR
Intervention: Single polymorphism and accumulation of culprit alleles
Number of subjects: 979
Study: 35364413

Group type: EXPERIMENTAL
Intervention: Transcutaneous vagal nerve stimulation (tVNS) - early stimulation (4 hours daily between Day 0 and 13)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Transcutaneous vagal nerve stimulation (tVNS) - late stimulation (4 hours daily between Day 14 and 28)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham tVNS (control condition) - early stimulation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham tVNS (control condition) - late stimulation
Number of subjects: 68
Study: 33249449

Group type: EXPERIMENTAL
Intervention: Mirror therapy and tDCS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mirror therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mirror therapy and sham tDCS
Number of subjects: 30
Study: 32228688

Group type: EXPERIMENTAL
Intervention: Organizational supports for evidence-based decision making
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Reasons for inappropriate termination
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Reasons for inappropriate continuation
Number of subjects: 376
Study: 35213547

Group type: EXPERIMENTAL
Intervention: Sarilumab, 200 or 400 mg subcutaneous injection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard of Care (SOC) alone
Number of subjects: 50
Study: 33179398

Group type: EXPERIMENTAL
Intervention: Co-transplantation of bone marrow-derived mesenchymal stem cells (MSCs) with hematopoietic stem cells (HSCs)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Hematopoietic stem cells (HSCs) only
Number of subjects: 59
Study: 36476193

Group type: EXPERIMENTAL
Intervention: Spirulina (SP) 2 g per day for 5 weeks
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Spirulina (SP)
Number of subjects: 179
Study: 32281254

Group type: EXPERIMENTAL
Intervention: 3D U‐Res‐Net_B model
Number of subjects: 122

Group type: COMPARATOR
Intervention: 3D U‐Res‐Net_O model
Number of subjects: 122

Group type: COMPARATOR
Intervention: 3D U‐Net model
Number of subjects: 122
Study: 35173212

Group type: COMPARATOR
Intervention: Fixed Intensity Group (FG)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Linear Increase Group (LG)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 69
Study: 33751322

Group type: EXPERIMENTAL
Intervention: Hot spot cell counting
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Visual estimation of hot spot areas
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both assessment methods (hot spot cell counting and visual estimation)
Number of subjects: 96
Study: 36028908

Group type: EXPERIMENTAL
Intervention: Couples Communication Skills Training (CCST)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Education control intervention
Number of subjects: 230
Study: 33904798

Group type: EXPERIMENTAL
Intervention: 1-day antibiotics (ciprofloxacin)
Number of subjects: 824

Group type: COMPARATOR
Intervention: 3-day antibiotics (ciprofloxacin)
Number of subjects: 824
Study: 34798266

Group type: EXPERIMENTAL
Intervention: Pleurotus eryngii meal
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 19
Study: 34500356

Group type: EXPERIMENTAL
Intervention: Bulk Traditional (BT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bulk&Go (BG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bulk&Flow (BF)
Number of subjects: 30
Study: 35340172

Group type: EXPERIMENTAL
Intervention: PD-1 antibody combined with total neoadjuvant chemoradiotherapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Training group model
Number of subjects: 38

Group type: COMPARATOR
Intervention: Test group model
Number of subjects: 38
Study: 34511134

Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg Q2W plus statin (atorvastatin 20 mg/day or rosuvastatin 10 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg Q2W plus statin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 33067121

Group type: EXPERIMENTAL
Intervention: mHealth intervention (mobile health technology-supported care)
Number of subjects: 1261

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1261

Group type: EXPERIMENTAL
Intervention: mHealth intervention (Better symptom management)
Number of subjects: 1261
Study: 33851476

Group type: EXPERIMENTAL
Intervention: Guiding Posture
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Guiding Hold
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Two-Handed Forearm Hold
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Finger, Thumb & Wrist Hold
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Cupped/Capped Fist Hold
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Wrap-Type Holds
Number of subjects: 172
Study: 32949091

Group type: EXPERIMENTAL
Intervention: BCAA (Livact®) for up to 4 years
Number of subjects: 156

Group type: COMPARATOR
Intervention: Surgery-alone
Number of subjects: 156
Study: 33406472

Group type: EXPERIMENTAL
Intervention: Pretomanid
Number of subjects: 0
Study: 35180784

Group type: EXPERIMENTAL
Intervention: External dacryocystorhinostomy (EX-DCR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transcanalicular multidiode laser dacryocystorhinostomy (TDL-DCR)
Number of subjects: 60
Study: 32457075

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 23
Study: 34162512

Group type: EXPERIMENTAL
Intervention: Group Counseling + Memory Training (GC + MT)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Memory Training (MT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Group Counseling (GC)
Number of subjects: 124
Study: 33342658

Group type: EXPERIMENTAL
Intervention: Endovascular aortic repair with aneurysm sac coil embolisation (ASCE)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard endovascular aortic repair (EVAR)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Endovascular aortic repair with ASCE
Number of subjects: 94
Study: 32883736

Group type: EXPERIMENTAL
Intervention: Adapted exercise-based fall prevention programme delivered by trained instructors
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Adapted exercise-based fall prevention programme
Number of subjects: 154
Study: 34843806

Group type: EXPERIMENTAL
Intervention: 2 mg dexamethasone with 0.5% ropivacaine and 0.2% lignocaine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Saline (control) with 0.5% ropivacaine and 0.2% lignocaine
Number of subjects: 66
Study: 32385867

Group type: EXPERIMENTAL
Intervention: Gauze soaked with 1:10 000 adrenaline
Number of subjects: 26

Group type: COMPARATOR
Intervention: Gauze soaked with 2% lidocaine without adrenaline
Number of subjects: 26
Study: 35575746

Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) ingestion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 32342894

Group type: EXPERIMENTAL
Intervention: Thermal Simulation System with varying surface temperatures of shell materials
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Contact duration with heated plates
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Different materials with varying thermal inertias
Number of subjects: 17
Study: 35971069

Group type: EXPERIMENTAL
Intervention: Step function model fitted on data from all treatment arms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Step function model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Step function models
Number of subjects: 0
Study: 36399083

Group type: EXPERIMENTAL
Intervention: Listening to self-selected music for 30 minutes daily for two weeks (Multi-Music Group - MG)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Listening to lullabies for 30 minutes daily for two weeks (Lullaby Group - LG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (CG) - no music intervention
Number of subjects: 120
Study: 32522060

Group type: EXPERIMENTAL
Intervention: Combined intervention (beetroot juice + folate)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Single intervention (beetroot juice + placebo)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (nitrate-depleted beetroot juice + placebo)
Number of subjects: 48
Study: 32304277

Group type: EXPERIMENTAL
Intervention: Framingham Risk Score for Hypertension
Number of subjects: 8027

Group type: EXPERIMENTAL
Intervention: ELSA-Brasil Risk Score
Number of subjects: 8027
Study: 35587247

Group type: EXPERIMENTAL
Intervention: Mandrax use
Number of subjects: 500
Study: 36048417

Group type: EXPERIMENTAL
Intervention: Ad5‐nCoV (5 × 10^10 viral particles/vial, 0.5 mL)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Batch 3 of Ad5‐nCoV
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Batch 1 of Ad5‐nCoV
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Batch 2 of Ad5‐nCoV
Number of subjects: 1050
Study: 33569869

Group type: EXPERIMENTAL
Intervention: Adventure therapy (AT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (based on cognitive-behavioral therapy)
Number of subjects: 0
Study: 32740449

Group type: EXPERIMENTAL
Intervention: Metronidazole treatment
Number of subjects: 858

Group type: EXPERIMENTAL
Intervention: Douching at least once
Number of subjects: 858

Group type: EXPERIMENTAL
Intervention: Women who had sex with women (WSW)
Number of subjects: 858

Group type: EXPERIMENTAL
Intervention: Age >21 years
Number of subjects: 858
Study: 35243620

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 476

Group type: COMPARATOR
Intervention: Control group (no childhood trauma history)
Number of subjects: 476
Study: 32921587

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 279

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study: 32770492

Group type: EXPERIMENTAL
Intervention: Reduction in excessive alcohol consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute alcohol consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Habitual alcohol consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol reduction and/or abstinence
Number of subjects: 0
Study: 35367469

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure at concentrations of 20, 50, and 150 μg/m3 for 4 hours
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure at concentrations of 50 μg/m3 and above
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure
Number of subjects: 13

Group type: COMPARATOR
Intervention: Filtered air (control)
Number of subjects: 13
Study: 33745088

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBMT) - three irradiations at 808 nm, 100 mW, 142 J/cm2, and 4 J per site
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32372407

Group type: EXPERIMENTAL
Intervention: Post-foaming dental gel (Group 1: device-enhanced; Group 2: toothbrush)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Post-foaming dental gel (Group 1: device-enhanced)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Post-foaming dental gel (Group 2: toothbrush)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Post-foaming dental gel (Group 1 and 2)
Number of subjects: 36
Study: 35879013

Group type: EXPERIMENTAL
Intervention: App-based treatment
Number of subjects: 262

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 262
Study: 34673258

Group type: EXPERIMENTAL
Intervention: Active anodal tDCS (a-tDCS) with DRG stimulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham tDCS with DRG stimulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: DRG stimulation alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: M1 tDCS
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: MEG-localized tDCS
Number of subjects: 16
Study: 32604254

Group type: EXPERIMENTAL
Intervention: Standard CR plus hatha yoga
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard CR
Number of subjects: 70
Study: 34268908

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine with pantoprazole (40 mg once daily for 9 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hydroxychloroquine without pantoprazole
Number of subjects: 24
Study: 33874800

Group type: EXPERIMENTAL
Intervention: Short trial - 20-minutes of HIIE, 30-second efforts at 100% of MAP interspersed by 30-seconds of passive recovery
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Long trial - 20-minutes of the short trial plus 10-minutes more of HIIE, decreasing 3% of MAP in each additional bout
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both trials
Number of subjects: 30
Study: 36071424

Group type: EXPERIMENTAL
Intervention: Tight glycemic control (TGC)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Standard care treatment
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Moderate to severe hypoglycemia
Number of subjects: 269

Group type: COMPARATOR
Intervention: No to mild hypoglycemia
Number of subjects: 269
Study: 34454883

Group type: EXPERIMENTAL
Intervention: Machine learning prediction model for CRT response
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Adaptive lasso model
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Participants in the 5th quintile of the prediction model
Number of subjects: 741
Study: 35678946

Group type: EXPERIMENTAL
Intervention: Social Communication Intervention
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Distance families had to travel to the university
Number of subjects: 78
Study: 32460589

Group type: EXPERIMENTAL
Intervention: G. sylvestre 300 mg b.i.d.
Number of subjects: 30
Study: 32167045

Group type: EXPERIMENTAL
Intervention: Self-gripping ProGrip (PG) mesh
Number of subjects: 99

Group type: COMPARATOR
Intervention: Sutured polypropylene (PL) mesh
Number of subjects: 99
Study: 35503591

Group type: EXPERIMENTAL
Intervention: Nasal mask
Number of subjects: 210

Group type: COMPARATOR
Intervention: Nasal prongs
Number of subjects: 210

Group type: COMPARATOR
Intervention: 4 hourly rotation of masks and prongs
Number of subjects: 210
Study: 33645192

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 40
Study: 33571477

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1878

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1878
Study: 32540383

Group type: EXPERIMENTAL
Intervention: PS-matched analysis
Number of subjects: 193620

Group type: COMPARATOR
Intervention: Reduced RCTs
Number of subjects: 193620
Study: 36199767

Group type: EXPERIMENTAL
Intervention: Submucosal Tunnel Endoscopic Resection (STER)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Endoscopic Mucosal Dissection (ESD)
Number of subjects: 272
Study: 34051912

Group type: EXPERIMENTAL
Intervention: Randomized multiple-baseline designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various randomization statistical tests
Number of subjects: 0
Study: 34853089

Group type: EXPERIMENTAL
Intervention: Ustekinumab (approximately 6 mg/kg single intravenous infusion, then subcutaneous injections of 90 mg every 8 weeks)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo (initially, then crossover to ustekinumab at week 24)
Number of subjects: 102